The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a sel...

অনুযায়ী Okui, Daisuke, Sasaki, Tomomitsu, Fushimi, Masahiko, Ohashi, Tetsuo
প্রকাশিত Clin Exp Nephrol (2019)

Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-...

অনুযায়ী Hosoya, Tatsuo, Sano, Takafumi, Sasaki, Tomomitsu, Fushimi, Masahiko, Ohashi, Tetsuo
প্রকাশিত Clin Exp Nephrol (2019)

Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study

অনুযায়ী Hosoya, Tatsuo, Sano, Takafumi, Sasaki, Tomomitsu, Fushimi, Masahiko, Ohashi, Tetsuo
প্রকাশিত Clin Exp Nephrol (2020)

Clinical pharmacological study of dotinurad administered to male and female elderly or young subjects

অনুযায়ী Nakatani, Hiroshi, Fushimi, Masahiko, Sasaki, Tomomitsu, Okui, Daisuke, Ohashi, Tetsuo
প্রকাশিত Clin Exp Nephrol (2019)

Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout

অনুযায়ী Hosoya, Tatsuo, Fushimi, Masahiko, Okui, Daisuke, Sasaki, Tomomitsu, Ohashi, Tetsuo
প্রকাশিত Clin Exp Nephrol (2019)

Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, mult...

অনুযায়ী Hosoya, Tatsuo, Sano, Takafumi, Sasaki, Tomomitsu, Fushimi, Masahiko, Ohashi, Tetsuo
প্রকাশিত Clin Exp Nephrol (2019)

Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad: a novel selective urate reabsorption inhibitor

অনুযায়ী Fukase, Hiroyuki, Okui, Daisuke, Sasaki, Tomomitsu, Fushimi, Masahiko, Ohashi, Tetsuo, Hosoya, Tatsuo
প্রকাশিত Clin Exp Nephrol (2019)